Gene Query: RALGAPA2

Dataset Description Geneva Score
Rorc disruption in human FG pancreatic cancer cells 40.65
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 39.12
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 38.77
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 35.11
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 35.11
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 32.72
RNA-seq analysis of AML cells in response to ASLAN003 32.54
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 30.99
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 27.05
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 26.93
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 26.93
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 26.12
A549 cells and MSR-A549 cells 26.12
Genome-wide functional assessment of enhancer activities in the human genome 24.75
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 24.75
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 24.44
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 24.44
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 24.0
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 24.0
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 23.95
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 23.95
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 22.98
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 22.98
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 22.13
Primary human trophoblast from term placenta 21.17
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 20.48
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 19.91
Transcription control by the ENL YEATS domain in acute leukemia 19.91
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 19.89
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 19.71
Differentially expressed genes post knock down of lincDUSP26 19.39
Gene expression analysis of immortalized human liver progenitor-like cells in culture 19.32
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 18.62
Hypoxic transcriptome of SQ20B human head and neck cancer cells 18.31
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 17.92
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 17.89
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 17.67
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 17.62
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 17.48
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 17.48
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 17.48
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 17.43
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 16.89
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 16.47
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 16.27
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 16.22
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 16.09
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 15.94
Gene expression changes associated with resistance to tagraxofusp (SL-401) 15.57
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 15.41
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 15.36
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 15.33
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 14.93
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 14.76
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 14.75
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 14.65
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 14.65
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 14.55
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 14.47
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 14.3
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 14.26
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 14.25
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 14.25
Overexpression and knockdown experiment for circCSNK1G3 14.17
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 13.76
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 13.65
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 13.61
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 13.61
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 13.55
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 13.54
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 13.32
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 13.27
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 13.27
Lysine benzoylation is a novel histone mark 13.26
Lysine benzoylation is a novel histone mark [RNA-seq] 13.26
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 13.25
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 13.14
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 12.96
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 12.77
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 12.4
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 12.32
RNA-sequencing of formalin fixed human primary melanoma tissue 12.25
BCL11B 12.24
The regulartory role of ZCCHC24 in splicing machinery 12.2
RNA-Sequencing of HepG2 cells treated with TGFBeta 12.0
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 11.9
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 11.83
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 11.82
Transcriptome of EBV-infected gastric cancer cell lines 11.8
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 11.66
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 11.65
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 11.64
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 11.61
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 11.6
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 11.54
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 11.52
Identifying the molecular mode of action of itraconazole in colorectal cancer 11.42
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 11.38
miRNAs affected by antagomiR-17 treatment 11.24
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 11.22
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 11.22
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 11.16
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 11.03
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 10.84
Investigation about fibroblasts of different origins in culture 10.71
Region-specific Innate Antiviral Responses of the Human Epididymis 10.63
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 10.58
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 10.58
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 10.46
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 10.35
mRNA expression profile of Lymphocytes by high-throuput sequencing 10.34
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 10.29
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 10.27
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 10.26
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 10.2
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 10.16
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 10.16
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 10.12
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 10.08
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 9.98
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 9.97
Effect of from Human Umbilical Vein Endothelial Cells 9.97
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 9.95
Evolution of a transcriptional regulator from a transmembrane nucleoporin 9.94
RNA-seq in HepG2 and IMR90 cells 9.94
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 9.94
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 9.86
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 9.85
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 9.76
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 9.76
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 9.75
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 9.63
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 9.62
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 9.6
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 9.55
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 9.55
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 9.52
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 9.5
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 9.47
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 9.47
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 9.44
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 9.41
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 9.41
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 9.39
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 9.33
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 9.32
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 9.31
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 9.31
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 9.23
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 9.18
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 9.18
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 9.16
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 9.04
Transcriptome analysis of virus infected tissues 8.91
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 8.91
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 8.91
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 8.82
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 8.74
LncRNA expression profiling of ischemic stroke patients 8.72
Role of CD133 molecule in WNT response and renal repair 8.71
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 8.7
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 8.69
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 8.69
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 8.67
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 8.63
The role of the Calcium-Sensing receptor in colorectal cancer 8.6
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 8.57
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 8.53
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 8.51
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 8.5
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 8.43
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 8.41
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 8.41
Androgen Receptor-regulated genes in prostate cancer cells 8.4
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 8.4
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 8.38
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 8.36
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 8.35
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 8.33
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 8.31
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 8.31
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 8.27
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 8.26
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 8.24
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 8.24
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 8.24
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 8.14
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 7.94
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 7.94
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 7.91
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 7.9
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 7.87
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 7.86
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 7.85
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 7.84
Exploring the RNA landscape of endothelial exosomes 7.77
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 7.72
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 7.72
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 7.72
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 7.72
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 7.7
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 7.69
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 7.66
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 7.65
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 7.64
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 7.64
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 7.64
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 7.63
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 7.6
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 7.58
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 7.56
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 7.54
Human cells contain natural double-stranded RNAs with potential regulatory capacity 7.5
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 7.48
RNA-seq of MCF10A cells and CAF 7.46
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 7.41
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  7.39
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 7.37
HNF1 regulates critical functions of the human epididymis epithelium. 7.28
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 7.28
snRNAs as regulators of alternative splicing 7.28
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 7.25
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 7.25
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 7.23
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 7.21
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 7.21
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 7.2
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 7.15
Overexpression of NFIB and YBX1 in MCF-7 cells 7.14
SRSF2 mutations impair hematopoiesis and alter exon recognition 7.12
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 7.12
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 7.11
circRNA profile in hypopharyngeal cancer 7.1
Lineage specific differentiation is influenced by state of human pluripotency 7.06
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 7.06
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.06
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.06
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 7.02
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 6.99
Transcriptome Profiling of Human Primary Monocytes 6.98
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 6.96
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 6.96
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.94
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 6.93
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 6.91
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.88
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 6.87
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 6.87
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 6.8
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 6.78
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 6.78
Regionally specified human pluripotent stem cell-derived astrocytes 6.74
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 6.68
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 6.65
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 6.65
Targeted enhancer activation by a subunit of the integrator complex 6.61
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 6.61
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 6.53
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 6.43
Interaction between mitoNEET and NAF-1 in cancer cells 6.33
Oncogenic MYC induces a dependency on the spliceosome in human cancer 6.3
Dysregulated immune system networks in war veterans with PTSD 6.24
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 6.23
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 6.21
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 6.17
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 6.17
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 6.16
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 6.13
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 6.13
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 6.12
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 6.11
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 6.11
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.04
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 5.92
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 5.92
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.83
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 5.78
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 5.77
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 5.76
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.75
RNA sequencing analysis of selumetinib-resistant CRC cells lines 5.73
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 5.69
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 5.69
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 5.64
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.64
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 5.61
Expression profiling of MCF-7 cells with treatment of TCDD 5.61
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 5.53
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 5.5
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 5.5
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 5.5
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 5.44
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 5.42
Gene profiling of human adult and pediatric liver cancer cells 5.38
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 5.3
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 5.29
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 5.28
Retinoic acid suppresses MYB in adenoid cystic carcinoma 5.28
Gene expression analysis upon mtDNA depletion 5.24
Gene expression analysis upon mtDNA depletion [RNA-seq] 5.24
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 5.14
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 5.1
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 5.04
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 5.02
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 5.01
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 5.01
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 5.0
Integrin signaling regulates YAP/TAZ to control skin homeostasis 5.0
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 4.96
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 4.95
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 4.93
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 4.93
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 4.91
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 4.89
Role of FGFR1 in neuronal devlopment 4.88
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 4.87
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 4.82
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 4.8
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 4.79
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.79
Dynamic 3D chromosomal landscapes in acute leukemia 4.75
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 4.75
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 4.75
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 4.74
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.67
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 4.66
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 4.55
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 4.51
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 4.46
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 4.44
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 4.39
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 4.39
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 4.38
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 4.38
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 4.37
Subtle asymmetry of gene expression in embryonic and foetal human brains 4.23
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 4.23
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 4.19
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 4.18
Gene expression analysis of human hepatocellular cancers 4.16
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 4.09
Intron retention induced by microsatellite expansions as a disease biomarker. 4.08
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 4.05
Global analyses of the effect of different cellular contexts on microRNA targeting 4.05
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 4.05
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 4.04
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 4.04
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 4.02
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 4.0
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 3.98
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 3.93
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 3.92
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 3.92
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.92
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 3.9
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 3.85
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 3.85
Mapping interactions for the TNIP2 hub protein 3.76
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 3.74
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.7
RNA Seq of Alagille liver biopsies 3.64
Alagille_Nodder 3.64
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.59
Zone dependent distinctive gene expression profile of the normal human liver tissue 3.51
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 3.43
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 3.43
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 3.39
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.39
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 3.37
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 3.33
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.3
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 3.3
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 3.29
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 3.18
JAK dependent survival of ALK- ALCL 3.16
The transcriptome of Kawasaki Disease arteritis 3.11
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 3.1
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 3.05
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 3.04
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.03
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 3.0
Loss of endometrial plasticity in recurrent pregnancy loss 3.0
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 2.96
HNRNPM-regulated splicing dependencies in prostate cancer 2.96
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 2.96
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 2.9
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.89
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.85
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 2.8
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 2.76
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 2.68
Finding missing proteins from epigenetically manipulated human cells 2.61
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 2.59
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 2.55
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 2.55
Gene expression profiling in metabolically heterogeneous human lung tumors 2.53
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.52
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 2.51
MHC Transcriptomic landscape at haplotype-specific resolution 2.46
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 2.43
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 2.41
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.38
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 2.33
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 2.33
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 2.31
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 2.3
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 2.15
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.1
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.1
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.07
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.07
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.07
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 2.02
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 2.0
Single-cell analysis of adult human ovary using 10X genomics 1.99
Changes in human endometrial gland transcriptome over the window of implantation 1.95
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 1.94
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.91
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.84
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.78
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 1.72
TAF1 is critical for AE driven leukemogenesis 1.72
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.71
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 1.64
Gene expression analysis of human adenomas. 1.64
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.63
RNA-sequencing of human tendon after injury 1.62
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 1.62
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 1.57
RNA-seq of primary patient AML samples 1.56
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.55
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.55
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.53
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 1.48
Effect of BMP inhibition or stimulation of primary human keratinocytes 1.44
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 1.44
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.41
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 1.32
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.3
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.29
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.26
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.21
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.18
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.17
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.14
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 1.12
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 1.12
Functional significance of the HIV-1 Tat signature amino acid residues 1.12
Gene expression profile of CRC-derived HILEC 1.11
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 1.04
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.0
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.0
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.97
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.87
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.87
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.86
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.84
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.83
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.81
Identification of expressed and conserved human non-coding RNAs 0.75
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.72
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.72
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.7
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.69
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.69
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.64
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 0.64
Dermal endothelial cells of type 2 diabetic patients 0.63
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.57
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.57
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.54
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.54
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.54
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.54
The role of CFTR in islet function 0.51
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.49
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.49
Functional astrocytes differentiated from hiPSCs 0.48
Transcriptomes in healthy and CHB fetal hearts 0.46
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.45
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.43
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.42
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.41
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.37
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.37
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.35
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.35
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.34
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.32
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 0.32
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.31
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.26
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.25
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.23
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.21
Expression analysis of the TAF1 syndrome 0.1
hNSCs siRNA NOVA2 0.06
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.04
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.02
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation